marketcaparena
Search

    TRAX

    First Tracks Biotherapeutics, Inc.

    Company overview

    Market capitalization
    $1.23B
    Employees
    104
    Latest publication
    2026-09-29
    About First Tracks Biotherapeutics, Inc.

    First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
    Total Revenue0USD0USD
    Research Development33,955,000USD41,465,000USD
    Selling General Administrative18,856,000USD9,815,000USD
    Total Operating Expenses52,811,000USD51,280,000USD
    Operating Income-52,811,000USD-51,280,000USD
    Interest Income2,328,000USD4,091,000USD
    Net Interest Income2,328,000USD4,091,000USD
    Income Before Tax-50,484,000USD-47,196,000USD
    Net Income-50,484,000USD-47,196,000USD
    Net Income From Continuing Ops-50,484,000USD-47,196,000USD
    Ebit-52,811,000USD-51,280,000USD
    Ebitda-52,686,000USD-50,674,000USD
    Depreciation And Amortization125,000USD606,000USD
    Reconciled Depreciation125,000USD606,000USD
    Total Other Income Expense Net2,327,000USD4,084,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Cost Of Revenue139,614,000USD152,345,000USD—
    Gross Profit-139,614,000USD-152,345,000USD—
    Research Development139,614,000USD152,345,000USD97,594,000USD
    Selling General Administrative39,392,000USD28,756,000USD20,867,000USD
    Unclassified Operating Expenses-139,614,000USD-152,345,000USD—
    Total Operating Expenses39,392,000USD28,756,000USD118,461,000USD
    Operating Income-179,006,000USD-181,101,000USD-118,461,000USD
    Income Before Tax-166,087,000USD-163,705,000USD-106,150,000USD
    Net Income-166,087,000USD-163,705,000USD-106,150,000USD
    Ebit-179,006,000USD-181,101,000USD-118,461,000USD
    Ebitda-178,447,000USD-178,704,000USD-116,085,000USD
    Depreciation And Amortization559,000USD2,397,000USD2,376,000USD
    Total Other Income Expense Net12,919,000USD17,396,000USD12,311,000USD
    Total Revenue—0USD0USD
    Interest Income—17,382,000USD12,313,000USD
    Net Interest Income—17,382,000USD12,313,000USD
    Net Income From Continuing Ops—-163,705,000USD-106,150,000USD
    Reconciled Depreciation—2,397,000USD2,376,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
    Total Assets183,140,000USD290,576,000USD—
    Cash And Equivalents168,018,000USD——
    Total Current Assets177,745,000USD289,402,000USD—
    Other Current Assets2,183,000USD2,947,000USD-385,373,000USD
    Other Non Current Assets0USD——
    Total Liabilities14,344,000USD——
    Total Current Liabilities12,447,000USD33,112,000USD—
    Other Current Liabilities7,458,000USD——
    Total Stockholder Equity168,796,000USD257,464,000USD391,596,000USD
    Total Equity Including Noncontrolling Interest168,796,000USD——
    Property Plant Equipment Net5,395,000USD1,174,000USD—
    Accounts Payable2,553,000USD7,496,000USD—
    Short Term Debt2,436,000USD——
    Common Stock35,000USD——
    Retained Earnings-24,576,000USD——
    Accumulated Other Comprehensive Income0USD-146,000USD391,596,000USD
    Total Liab—33,112,000USD-391,596,000USD
    Other Current Liab—25,616,000USD—
    Cash—248,469,000USD—
    Cash And Short Term Investments—286,455,000USD385,373,000USD
    Net Debt—-248,469,000USD—
    Short Term Investments—37,986,000USD—
    Property Plant Equipment Gross—8,346,000USD—
    Common Stock Shares Outstanding—34,748,841shares34,748,841shares
    Non Current Assets Total—1,174,000USD—
    Non Current Liabilities Total—0USD-391,596,000USD
    Net Working Capital—256,290,000USD—
    Unclassified Equity—257,610,000USD—
    Unclassified Non Current Liabilities——-391,596,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Assets330,545,000USD441,891,000USD444,109,000USD
    Other Current Assets4,762,000USD4,560,000USD7,651,000USD
    Total Liab43,055,000USD50,295,000USD34,260,000USD
    Total Stockholder Equity287,490,000USD391,596,000USD409,849,000USD
    Other Current Liab25,832,000USD30,473,000USD14,021,000USD
    Common Stock287,514,000USD391,291,000USD410,646,000USD
    Cash238,196,000USD123,080,000USD35,965,000USD
    Cash And Short Term Investments311,638,000USD385,373,000USD390,904,000USD
    Total Current Assets316,400,000USD389,933,000USD398,555,000USD
    Total Current Liabilities31,023,000USD36,183,000USD18,223,000USD
    Net Debt-224,084,000USD-107,043,000USD-18,151,000USD
    Short Term Debt2,080,000USD1,925,000USD1,777,000USD
    Short Long Term Debt Total14,112,000USD16,037,000USD17,814,000USD
    Short Term Investments73,442,000USD262,293,000USD354,939,000USD
    Accounts Payable3,111,000USD3,785,000USD2,425,000USD
    Property Plant Equipment Net13,889,000USD16,232,000USD18,272,000USD
    Accumulated Other Comprehensive Income-24,000USD305,000USD-797,000USD
    Non Current Assets Total14,145,000USD51,958,000USD45,554,000USD
    Non Current Liabilities Total12,032,000USD14,112,000USD16,037,000USD
    Non Currrent Assets Other256,000USD256,000USD256,000USD
    Unclassified Non Current Liabilities12,032,000USD14,112,000USD16,037,000USD
    Capital Stock—391,291,000USD410,646,000USD
    Long Term Investments—35,470,000USD27,026,000USD
    Property Plant Equipment Gross—22,831,000USD24,490,000USD
    Common Stock Shares Outstanding—34,748,841shares34,748,841shares
    Net Working Capital—353,750,000USD380,332,000USD
    Unclassified Equity—-391,291,000USD-410,646,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
    Net Income-50,484,000USD-47,196,000USD
    Depreciation125,000USD606,000USD
    Stock Based Compensation11,503,000USD7,746,000USD
    Other Non Cash Items-8,000USD-1,667,000USD
    Change In Working Capital6,303,000USD-4,495,000USD
    Total Cash From Operating Activities-32,561,000USD-45,006,000USD
    Capital Expenditures-17,000USD-35,000USD
    Free Cash Flow-32,578,000USD-45,041,000USD
    Investments35,000,000USD14,882,000USD
    Total Cashflows From Investing Activities34,983,000USD14,847,000USD
    Total Cash From Financing Activities7,851,000USD5,716,000USD
    Change In Cash10,273,000USD-24,443,000USD
    Begin Period Cash Flow238,196,000USD123,080,000USD
    End Period Cash Flow248,469,000USD98,637,000USD
    Other Cashflows From Financing Activities7,851,000USD5,716,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Net Income-166,087,000USD-163,705,000USD-106,150,000USD
    Depreciation2,423,000USD2,397,000USD2,376,000USD
    Stock Based Compensation32,299,999USD26,827,000USD18,393,000USD
    Other Non Cash Items-10,041,999USD-10,313,000USD-10,521,000USD
    Change In Working Capital-1,520,000USD18,988,000USD2,898,000USD
    Total Cash From Operating Activities-142,926,000USD-125,806,000USD-93,004,000USD
    Capital Expenditures-87,000USD-358,000USD-807,000USD
    Free Cash Flow-143,012,000USD-126,164,000USD-93,811,000USD
    Total Cashflows From Investing Activities228,032,000USD95,398,000USD144,754,000USD
    Total Cash From Financing Activities30,010,000USD117,523,000USD-87,093,000USD
    Change In Cash115,116,000USD87,115,000USD-35,343,000USD
    Begin Period Cash Flow123,080,000USD35,965,000USD71,308,000USD
    End Period Cash Flow238,196,000USD123,080,000USD35,965,000USD
    Other Cashflows From Investing Activities228,119,000USD——
    Other Cashflows From Financing Activities30,010,000USD——
    Investments—95,756,000USD145,561,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.